-
-edge technologies, including genetically engineered mouse models, patient-derived models, single-cell and spatial genomics, organoid systems, and preclinical therapeutic studies. Learn more about our
-
the non-human primate (NHP) model by exploring innovative mRNA constructs for immunogen delivery that can elicit both protective and therapeutic B and T cell responses. Recently, Dr. Williams was also
-
induce more protective immune responses in the non-human primate (NHP) model by exploring innovative mRNA constructs for immunogen delivery that can elicit both protective and therapeutic B and T cell
-
-throughput genomic screening approaches, primary cell culture systems, and animal models of influenza disease. For more information visit https://mgm.duke.edu/faculty-and-research/primary-faculty/nicholas